Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6500
0.00 (0.00%)
Sep 5, 2025, 4:10 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 224.27 million as of September 5, 2025. Its market cap has increased by 35.47% in one year.
Market Cap
224.27M
Enterprise Value
209.98M
Revenue
76.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 224.27M, a decrease of -44.64%. That is a compound annual growth rate of -10.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 224.27M | -15.55% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | 345.84M | -14.63% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 101.49B |
| Pro Medicus | 30.97B |
| Cochlear | 19.54B |
| Sonic Healthcare | 11.37B |
| Ramsay Health Care | 7.84B |
| Ansell | 4.99B |
| Telix Pharmaceuticals | 4.66B |
| Mesoblast | 2.55B |